Global Women Infertility Market

Women Infertility Comprehensive Study by Type (Media & Consumables, Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others), Accessories), Treatment Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgery, Other Infertility Treatment Procedures), End-User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes) Players and Region - Global Market Outlook to 2026

Women Infertility Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 7.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Women Infertility Market Scope
Infertility is the inability of a person to reproduce naturally. Women infertility is the inability of a female to become pregnant and carry pregnancy to full term. It is the most common issue faced by couples trying to get conceived. The most commonly diagnosed causes of female infertility are issues with ovulation, hormonal imbalance, anatomical disorders of the reproductive system such as damage caused to the fallopian tubes, the uterus, or the cervix, overuse of alcohol or drugs and other. Increasing prevalence of polycystic ovarian syndrome (PCOS) and other hormonal disorders, changing lifestyle, obesity, and increasing awareness about advanced fertility techniques are key driving agent to boost the fertility diagnosis & treatment market across the globe.

According to AMA, the Global Women Infertility market is expected to see growth rate of 7.7% and may see market size of USD2.4 Billion by 2026.

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Women Infertility market throughout the predicted period.

Thermo Fisher Scientific Inc. (United States), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (United States), The Baker Company Inc. (United States), Kitazato (Japan), Rocket Medical Plc. (United Kingdom), IHMedical A/S (Denmark) and Hamilton Throne Ltd. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are MedGyn Products, Inc. (United States), ZEISS Group (Germany) and SoMATEX Medical Technologies GmbH (Germany).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global Women Infertility market by Type (Media & Consumables, Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others) and Accessories) and Region with country level break-up.

On the basis of geography, the market of Women Infertility has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In April 2018, Baker Ruskinn (UK) entered into a partnership with I&L Biosystems UK Ltd. (UK) as its UK sales partner with the aim to expand its sales and distribution and strengthen its presence in the UK market
In March 2018, Vitrolife AB (Sweden) received approval for the sale of its time-lapse incubator EmbryoScope+ in the US. Through this the company expanded its product sale and market visibility in the US infertility treatment. and In March 2018, Genea Limited (Australia) expanded its market presence in Melbourne by establishing a new fertility clinic in Melbourne


Market Trend
  • Advancements in Infertility Treatment Devices
  • Increase in the Use of Time-Lapse Technology

Market Drivers
  • Declining Fertility Rate
  • Rising Number of Fertility Clinics Worldwide

Opportunities
  • Improving Healthcare Infrastructure in Developing Countries
  • Increasing Medical Tourism Due to Low Treatment Costs

Restraints
  • High Procedural Cost of Assisted Reproductive Techniques in Developed Countries
  • Reduced Efficacy Among Older Women

Challenges
  • Concerns Related to Art Procedures
  • Unsupportive Government Regulations
  • Shortage of Skilled Medical Professionals in Developing Countries


Report Objectives / Segmentation Covered

By Type
  • Media & Consumables
  • Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others)
  • Accessories
By Treatment Procedure
  • Assisted Reproductive Technology
  • Artificial Insemination
  • Fertility Surgery
  • Other Infertility Treatment Procedures

By End-User
  • Fertility Centers
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Declining Fertility Rate
      • 3.2.2. Rising Number of Fertility Clinics Worldwide
    • 3.3. Market Challenges
      • 3.3.1. Concerns Related to Art Procedures
      • 3.3.2. Unsupportive Government Regulations
      • 3.3.3. Shortage of Skilled Medical Professionals in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Advancements in Infertility Treatment Devices
      • 3.4.2. Increase in the Use of Time-Lapse Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Women Infertility, by Type, Treatment Procedure, End-User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Women Infertility (Value)
      • 5.2.1. Global Women Infertility by: Type (Value)
        • 5.2.1.1. Media & Consumables
        • 5.2.1.2. Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others)
        • 5.2.1.3. Accessories
      • 5.2.2. Global Women Infertility by: Treatment Procedure (Value)
        • 5.2.2.1. Assisted Reproductive Technology
        • 5.2.2.2. Artificial Insemination
        • 5.2.2.3. Fertility Surgery
        • 5.2.2.4. Other Infertility Treatment Procedures
      • 5.2.3. Global Women Infertility by: End-User (Value)
        • 5.2.3.1. Fertility Centers
        • 5.2.3.2. Hospitals & Surgical Clinics
        • 5.2.3.3. Cryobanks
        • 5.2.3.4. Research Institutes
      • 5.2.4. Global Women Infertility Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Women Infertility (Price)
      • 5.3.1. Global Women Infertility by: Type (Price)
  • 6. Women Infertility: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Esco Micro Pte. Ltd. (Singapore)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Genea Limited (Australia)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. IVFtech ApS (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Irvine Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. The Baker Company Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Kitazato (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Rocket Medical Plc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. IHMedical A/S (Denmark)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hamilton Throne Ltd. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Women Infertility Sale, by Type, Treatment Procedure, End-User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Women Infertility (Value)
      • 7.2.1. Global Women Infertility by: Type (Value)
        • 7.2.1.1. Media & Consumables
        • 7.2.1.2. Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others)
        • 7.2.1.3. Accessories
      • 7.2.2. Global Women Infertility by: Treatment Procedure (Value)
        • 7.2.2.1. Assisted Reproductive Technology
        • 7.2.2.2. Artificial Insemination
        • 7.2.2.3. Fertility Surgery
        • 7.2.2.4. Other Infertility Treatment Procedures
      • 7.2.3. Global Women Infertility by: End-User (Value)
        • 7.2.3.1. Fertility Centers
        • 7.2.3.2. Hospitals & Surgical Clinics
        • 7.2.3.3. Cryobanks
        • 7.2.3.4. Research Institutes
      • 7.2.4. Global Women Infertility Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Women Infertility (Price)
      • 7.3.1. Global Women Infertility by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Women Infertility: by Type(USD Billion)
  • Table 2. Women Infertility Media & Consumables , by Region USD Billion (2015-2020)
  • Table 3. Women Infertility Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others) , by Region USD Billion (2015-2020)
  • Table 4. Women Infertility Accessories , by Region USD Billion (2015-2020)
  • Table 5. Women Infertility: by Treatment Procedure(USD Billion)
  • Table 6. Women Infertility Assisted Reproductive Technology , by Region USD Billion (2015-2020)
  • Table 7. Women Infertility Artificial Insemination , by Region USD Billion (2015-2020)
  • Table 8. Women Infertility Fertility Surgery , by Region USD Billion (2015-2020)
  • Table 9. Women Infertility Other Infertility Treatment Procedures , by Region USD Billion (2015-2020)
  • Table 10. Women Infertility: by End-User(USD Billion)
  • Table 11. Women Infertility Fertility Centers , by Region USD Billion (2015-2020)
  • Table 12. Women Infertility Hospitals & Surgical Clinics , by Region USD Billion (2015-2020)
  • Table 13. Women Infertility Cryobanks , by Region USD Billion (2015-2020)
  • Table 14. Women Infertility Research Institutes , by Region USD Billion (2015-2020)
  • Table 15. South America Women Infertility, by Country USD Billion (2015-2020)
  • Table 16. South America Women Infertility, by Type USD Billion (2015-2020)
  • Table 17. South America Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 18. South America Women Infertility, by End-User USD Billion (2015-2020)
  • Table 19. Brazil Women Infertility, by Type USD Billion (2015-2020)
  • Table 20. Brazil Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 21. Brazil Women Infertility, by End-User USD Billion (2015-2020)
  • Table 22. Argentina Women Infertility, by Type USD Billion (2015-2020)
  • Table 23. Argentina Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 24. Argentina Women Infertility, by End-User USD Billion (2015-2020)
  • Table 25. Rest of South America Women Infertility, by Type USD Billion (2015-2020)
  • Table 26. Rest of South America Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 27. Rest of South America Women Infertility, by End-User USD Billion (2015-2020)
  • Table 28. Asia Pacific Women Infertility, by Country USD Billion (2015-2020)
  • Table 29. Asia Pacific Women Infertility, by Type USD Billion (2015-2020)
  • Table 30. Asia Pacific Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 31. Asia Pacific Women Infertility, by End-User USD Billion (2015-2020)
  • Table 32. China Women Infertility, by Type USD Billion (2015-2020)
  • Table 33. China Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 34. China Women Infertility, by End-User USD Billion (2015-2020)
  • Table 35. Japan Women Infertility, by Type USD Billion (2015-2020)
  • Table 36. Japan Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 37. Japan Women Infertility, by End-User USD Billion (2015-2020)
  • Table 38. India Women Infertility, by Type USD Billion (2015-2020)
  • Table 39. India Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 40. India Women Infertility, by End-User USD Billion (2015-2020)
  • Table 41. South Korea Women Infertility, by Type USD Billion (2015-2020)
  • Table 42. South Korea Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 43. South Korea Women Infertility, by End-User USD Billion (2015-2020)
  • Table 44. Taiwan Women Infertility, by Type USD Billion (2015-2020)
  • Table 45. Taiwan Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 46. Taiwan Women Infertility, by End-User USD Billion (2015-2020)
  • Table 47. Australia Women Infertility, by Type USD Billion (2015-2020)
  • Table 48. Australia Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 49. Australia Women Infertility, by End-User USD Billion (2015-2020)
  • Table 50. Rest of Asia-Pacific Women Infertility, by Type USD Billion (2015-2020)
  • Table 51. Rest of Asia-Pacific Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 52. Rest of Asia-Pacific Women Infertility, by End-User USD Billion (2015-2020)
  • Table 53. Europe Women Infertility, by Country USD Billion (2015-2020)
  • Table 54. Europe Women Infertility, by Type USD Billion (2015-2020)
  • Table 55. Europe Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 56. Europe Women Infertility, by End-User USD Billion (2015-2020)
  • Table 57. Germany Women Infertility, by Type USD Billion (2015-2020)
  • Table 58. Germany Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 59. Germany Women Infertility, by End-User USD Billion (2015-2020)
  • Table 60. France Women Infertility, by Type USD Billion (2015-2020)
  • Table 61. France Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 62. France Women Infertility, by End-User USD Billion (2015-2020)
  • Table 63. Italy Women Infertility, by Type USD Billion (2015-2020)
  • Table 64. Italy Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 65. Italy Women Infertility, by End-User USD Billion (2015-2020)
  • Table 66. United Kingdom Women Infertility, by Type USD Billion (2015-2020)
  • Table 67. United Kingdom Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 68. United Kingdom Women Infertility, by End-User USD Billion (2015-2020)
  • Table 69. Netherlands Women Infertility, by Type USD Billion (2015-2020)
  • Table 70. Netherlands Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 71. Netherlands Women Infertility, by End-User USD Billion (2015-2020)
  • Table 72. Rest of Europe Women Infertility, by Type USD Billion (2015-2020)
  • Table 73. Rest of Europe Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 74. Rest of Europe Women Infertility, by End-User USD Billion (2015-2020)
  • Table 75. MEA Women Infertility, by Country USD Billion (2015-2020)
  • Table 76. MEA Women Infertility, by Type USD Billion (2015-2020)
  • Table 77. MEA Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 78. MEA Women Infertility, by End-User USD Billion (2015-2020)
  • Table 79. Middle East Women Infertility, by Type USD Billion (2015-2020)
  • Table 80. Middle East Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 81. Middle East Women Infertility, by End-User USD Billion (2015-2020)
  • Table 82. Africa Women Infertility, by Type USD Billion (2015-2020)
  • Table 83. Africa Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 84. Africa Women Infertility, by End-User USD Billion (2015-2020)
  • Table 85. North America Women Infertility, by Country USD Billion (2015-2020)
  • Table 86. North America Women Infertility, by Type USD Billion (2015-2020)
  • Table 87. North America Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 88. North America Women Infertility, by End-User USD Billion (2015-2020)
  • Table 89. United States Women Infertility, by Type USD Billion (2015-2020)
  • Table 90. United States Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 91. United States Women Infertility, by End-User USD Billion (2015-2020)
  • Table 92. Canada Women Infertility, by Type USD Billion (2015-2020)
  • Table 93. Canada Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 94. Canada Women Infertility, by End-User USD Billion (2015-2020)
  • Table 95. Mexico Women Infertility, by Type USD Billion (2015-2020)
  • Table 96. Mexico Women Infertility, by Treatment Procedure USD Billion (2015-2020)
  • Table 97. Mexico Women Infertility, by End-User USD Billion (2015-2020)
  • Table 98. Women Infertility: by Type(USD/Units)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Women Infertility: by Type(USD Billion)
  • Table 110. Women Infertility Media & Consumables , by Region USD Billion (2021-2026)
  • Table 111. Women Infertility Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others) , by Region USD Billion (2021-2026)
  • Table 112. Women Infertility Accessories , by Region USD Billion (2021-2026)
  • Table 113. Women Infertility: by Treatment Procedure(USD Billion)
  • Table 114. Women Infertility Assisted Reproductive Technology , by Region USD Billion (2021-2026)
  • Table 115. Women Infertility Artificial Insemination , by Region USD Billion (2021-2026)
  • Table 116. Women Infertility Fertility Surgery , by Region USD Billion (2021-2026)
  • Table 117. Women Infertility Other Infertility Treatment Procedures , by Region USD Billion (2021-2026)
  • Table 118. Women Infertility: by End-User(USD Billion)
  • Table 119. Women Infertility Fertility Centers , by Region USD Billion (2021-2026)
  • Table 120. Women Infertility Hospitals & Surgical Clinics , by Region USD Billion (2021-2026)
  • Table 121. Women Infertility Cryobanks , by Region USD Billion (2021-2026)
  • Table 122. Women Infertility Research Institutes , by Region USD Billion (2021-2026)
  • Table 123. South America Women Infertility, by Country USD Billion (2021-2026)
  • Table 124. South America Women Infertility, by Type USD Billion (2021-2026)
  • Table 125. South America Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 126. South America Women Infertility, by End-User USD Billion (2021-2026)
  • Table 127. Brazil Women Infertility, by Type USD Billion (2021-2026)
  • Table 128. Brazil Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 129. Brazil Women Infertility, by End-User USD Billion (2021-2026)
  • Table 130. Argentina Women Infertility, by Type USD Billion (2021-2026)
  • Table 131. Argentina Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 132. Argentina Women Infertility, by End-User USD Billion (2021-2026)
  • Table 133. Rest of South America Women Infertility, by Type USD Billion (2021-2026)
  • Table 134. Rest of South America Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 135. Rest of South America Women Infertility, by End-User USD Billion (2021-2026)
  • Table 136. Asia Pacific Women Infertility, by Country USD Billion (2021-2026)
  • Table 137. Asia Pacific Women Infertility, by Type USD Billion (2021-2026)
  • Table 138. Asia Pacific Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 139. Asia Pacific Women Infertility, by End-User USD Billion (2021-2026)
  • Table 140. China Women Infertility, by Type USD Billion (2021-2026)
  • Table 141. China Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 142. China Women Infertility, by End-User USD Billion (2021-2026)
  • Table 143. Japan Women Infertility, by Type USD Billion (2021-2026)
  • Table 144. Japan Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 145. Japan Women Infertility, by End-User USD Billion (2021-2026)
  • Table 146. India Women Infertility, by Type USD Billion (2021-2026)
  • Table 147. India Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 148. India Women Infertility, by End-User USD Billion (2021-2026)
  • Table 149. South Korea Women Infertility, by Type USD Billion (2021-2026)
  • Table 150. South Korea Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 151. South Korea Women Infertility, by End-User USD Billion (2021-2026)
  • Table 152. Taiwan Women Infertility, by Type USD Billion (2021-2026)
  • Table 153. Taiwan Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 154. Taiwan Women Infertility, by End-User USD Billion (2021-2026)
  • Table 155. Australia Women Infertility, by Type USD Billion (2021-2026)
  • Table 156. Australia Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 157. Australia Women Infertility, by End-User USD Billion (2021-2026)
  • Table 158. Rest of Asia-Pacific Women Infertility, by Type USD Billion (2021-2026)
  • Table 159. Rest of Asia-Pacific Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 160. Rest of Asia-Pacific Women Infertility, by End-User USD Billion (2021-2026)
  • Table 161. Europe Women Infertility, by Country USD Billion (2021-2026)
  • Table 162. Europe Women Infertility, by Type USD Billion (2021-2026)
  • Table 163. Europe Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 164. Europe Women Infertility, by End-User USD Billion (2021-2026)
  • Table 165. Germany Women Infertility, by Type USD Billion (2021-2026)
  • Table 166. Germany Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 167. Germany Women Infertility, by End-User USD Billion (2021-2026)
  • Table 168. France Women Infertility, by Type USD Billion (2021-2026)
  • Table 169. France Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 170. France Women Infertility, by End-User USD Billion (2021-2026)
  • Table 171. Italy Women Infertility, by Type USD Billion (2021-2026)
  • Table 172. Italy Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 173. Italy Women Infertility, by End-User USD Billion (2021-2026)
  • Table 174. United Kingdom Women Infertility, by Type USD Billion (2021-2026)
  • Table 175. United Kingdom Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 176. United Kingdom Women Infertility, by End-User USD Billion (2021-2026)
  • Table 177. Netherlands Women Infertility, by Type USD Billion (2021-2026)
  • Table 178. Netherlands Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 179. Netherlands Women Infertility, by End-User USD Billion (2021-2026)
  • Table 180. Rest of Europe Women Infertility, by Type USD Billion (2021-2026)
  • Table 181. Rest of Europe Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 182. Rest of Europe Women Infertility, by End-User USD Billion (2021-2026)
  • Table 183. MEA Women Infertility, by Country USD Billion (2021-2026)
  • Table 184. MEA Women Infertility, by Type USD Billion (2021-2026)
  • Table 185. MEA Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 186. MEA Women Infertility, by End-User USD Billion (2021-2026)
  • Table 187. Middle East Women Infertility, by Type USD Billion (2021-2026)
  • Table 188. Middle East Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 189. Middle East Women Infertility, by End-User USD Billion (2021-2026)
  • Table 190. Africa Women Infertility, by Type USD Billion (2021-2026)
  • Table 191. Africa Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 192. Africa Women Infertility, by End-User USD Billion (2021-2026)
  • Table 193. North America Women Infertility, by Country USD Billion (2021-2026)
  • Table 194. North America Women Infertility, by Type USD Billion (2021-2026)
  • Table 195. North America Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 196. North America Women Infertility, by End-User USD Billion (2021-2026)
  • Table 197. United States Women Infertility, by Type USD Billion (2021-2026)
  • Table 198. United States Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 199. United States Women Infertility, by End-User USD Billion (2021-2026)
  • Table 200. Canada Women Infertility, by Type USD Billion (2021-2026)
  • Table 201. Canada Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 202. Canada Women Infertility, by End-User USD Billion (2021-2026)
  • Table 203. Mexico Women Infertility, by Type USD Billion (2021-2026)
  • Table 204. Mexico Women Infertility, by Treatment Procedure USD Billion (2021-2026)
  • Table 205. Mexico Women Infertility, by End-User USD Billion (2021-2026)
  • Table 206. Women Infertility: by Type(USD/Units)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Women Infertility: by Type USD Billion (2015-2020)
  • Figure 5. Global Women Infertility: by Treatment Procedure USD Billion (2015-2020)
  • Figure 6. Global Women Infertility: by End-User USD Billion (2015-2020)
  • Figure 7. South America Women Infertility Share (%), by Country
  • Figure 8. Asia Pacific Women Infertility Share (%), by Country
  • Figure 9. Europe Women Infertility Share (%), by Country
  • Figure 10. MEA Women Infertility Share (%), by Country
  • Figure 11. North America Women Infertility Share (%), by Country
  • Figure 12. Global Women Infertility: by Type USD/Units (2015-2020)
  • Figure 13. Global Women Infertility share by Players 2020 (%)
  • Figure 14. Global Women Infertility share by Players (Top 3) 2020(%)
  • Figure 15. Global Women Infertility share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 19. Esco Micro Pte. Ltd. (Singapore) Revenue, Net Income and Gross profit
  • Figure 20. Esco Micro Pte. Ltd. (Singapore) Revenue: by Geography 2020
  • Figure 21. Genea Limited (Australia) Revenue, Net Income and Gross profit
  • Figure 22. Genea Limited (Australia) Revenue: by Geography 2020
  • Figure 23. IVFtech ApS (Denmark) Revenue, Net Income and Gross profit
  • Figure 24. IVFtech ApS (Denmark) Revenue: by Geography 2020
  • Figure 25. Irvine Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Irvine Scientific (United States) Revenue: by Geography 2020
  • Figure 27. The Baker Company Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. The Baker Company Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Kitazato (Japan) Revenue, Net Income and Gross profit
  • Figure 30. Kitazato (Japan) Revenue: by Geography 2020
  • Figure 31. Rocket Medical Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Rocket Medical Plc. (United Kingdom) Revenue: by Geography 2020
  • Figure 33. IHMedical A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. IHMedical A/S (Denmark) Revenue: by Geography 2020
  • Figure 35. Hamilton Throne Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Hamilton Throne Ltd. (United States) Revenue: by Geography 2020
  • Figure 37. Global Women Infertility: by Type USD Billion (2021-2026)
  • Figure 38. Global Women Infertility: by Treatment Procedure USD Billion (2021-2026)
  • Figure 39. Global Women Infertility: by End-User USD Billion (2021-2026)
  • Figure 40. South America Women Infertility Share (%), by Country
  • Figure 41. Asia Pacific Women Infertility Share (%), by Country
  • Figure 42. Europe Women Infertility Share (%), by Country
  • Figure 43. MEA Women Infertility Share (%), by Country
  • Figure 44. North America Women Infertility Share (%), by Country
  • Figure 45. Global Women Infertility: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific Inc. (United States)
  • Esco Micro Pte. Ltd. (Singapore)
  • Genea Limited (Australia)
  • IVFtech ApS (Denmark)
  • Irvine Scientific (United States)
  • The Baker Company Inc. (United States)
  • Kitazato (Japan)
  • Rocket Medical Plc. (United Kingdom)
  • IHMedical A/S (Denmark)
  • Hamilton Throne Ltd. (United States)
Additional players considered in the study are as follows:
MedGyn Products, Inc. (United States) , ZEISS Group (Germany) , SoMATEX Medical Technologies GmbH (Germany)
Select User Access Type

Key Highlights of Report


Sep 2021 248 Pages 58 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Women Infertility Market Quantitative research analysis
Global Women Infertility Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Women Infertility study can be customized to meet your requirements. The market size breakdown by type [Media & Consumables, Equipment (Microscopes, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators Systems, Incubators and Others) and Accessories], by end use application [].
The Women Infertility Market is gaining popularity and expected to see strong valuation by 2026.
According to AMA, the Global Women Infertility market is expected to see growth rate of 7.7%.

Know More About Global Women Infertility Market Report?

Have a Query? Click Here

Other Related Reports

Nutraceutical Supplements Comprehensive Study by End User (Men, Women), Product Form (Capsules, Liquids, Tablets, Powder & Granules, Others), Distribution Channel (Supermarkets and Hypermarkets, Co...
$ 3750
Powder Dietary Supplements Comprehensive Study by Type (Amino Acids Powder Dietary Supplements, Botanical Powder Dietary Supplements, Vitamins & Minerals Powder Dietary Supplements, Others), Applicat...
$ 3750
Recombinant Hirudin Medicine Comprehensive Study by Type (12000 ATU / mg, 16000 ATU / mg, 16000 ATU / mg, Others), Application (Thrombosis Disease, Tumor Disease, Others), End Use (Hospitals, Medical...
$ 3350
Contraceptive Patch Comprehensive Study by Application (Hospitals, Homecare, Gynecology Centers, Clinics, Ambulatory Surgical Centers (ASC)), Distribution Channel (Online, Offline), Age (Age 15-24, A...
$ 3350
Postoperative Pain Therapeutics Comprehensive Study by Type (Opioids, NSAIDS, Local anesthetics, Tricyclic antidepressants, Antiepileptic drugs, Others), Route of Administration (Oral, Intramuscular,...
$ 3650
Valerian Root Extract Comprehensive Study by Type (High Purity, Low Purity), Application (Cosmetic, Food and Beverages, Medical), Distribution Channel (Offline, Online), End User (Male, Female) Playe...
$ 3500